Sarms
Can SARM AC-262 536 Treat Muscle Wasting Diseases? Muscle-wasting diseases, also called muscle atrophy disorders, cause a slow but steady loss of muscle mass. Conditions
Testosterone Replacement Therapy (TRT) is used to treat men with low testosterone levels associated with aging, medical conditions, or lifestyle factors. When combined with Human Chorionic Gonadotropin (HCG), the therapy may help maintain intratesticular testosterone production and support testicular function during treatment.
This article reviews the evidence of combining TRT with HCG. It also examines its potential effects on men’s health, and explains the role of TRT, how HCG interacts with luteinizing hormone receptors, and the associated benefits, risks, and clinical considerations.
Discover more about HCG here.
Testosterone Replacement Therapy (TRT) is used to treat men with hypogonadism, a condition caused by low testosterone levels. Testosterone is involved in muscle mass, bone density, libido, mood, energy levels, and sperm production. Low testosterone levels are associated with fatigue, reduced sexual function, decreased muscle mass, low bone density, and mood changes.
TRT restores testosterone levels and improves symptoms associated with testosterone deficiency, including sexual function, lean body mass, bone density, and energy levels.
However, exogenous testosterone therapy suppresses luteinizing hormone (LH) and follicle-stimulating hormone (FSH) signaling, which can reduce intratesticular testosterone production and spermatogenesis. This may affect fertility in men receiving TRT.
Human Chorionic Gonadotropin (HCG) is a hormone that stimulates luteinizing hormone (LH) receptors in the testes. LH signaling helps maintain testosterone production inside the testes, which is required for sperm production.
Testosterone Replacement Therapy can suppress the luteinizing hormone (LH) and follicle-stimulating hormone (FSH) production. This may lower intratesticular testosterone levels and reduce sperm production. HCG with TRT is used to help maintain intratesticular testosterone levels and support spermatogenesis during treatment.
United States Research shows that low-dose HCG can maintain intratesticular testosterone levels in men receiving exogenous testosterone therapy. United States Studies also show that HCG may help preserve spermatogenesis and fertility during TRT.
Human Menopausal Gonadotropin (HMG) contains both luteinizing hormone (LH) and follicle-stimulating hormone (FSH) activity. Unlike HCG, which mainly stimulates LH receptors, HMG also provides FSH activity, which is involved in sperm production.
Discover HMG from Direct SARMs United States, combining LH and FSH to enhance testicular stimulation and support spermatogenesis alongside testosterone therapy.
Combining TRT with HCG may offer several theoretical benefits, according to current United States studies:
Shop Peptide Supplies from Direct SARMs United States for all your reconstitution requirements.
TRT with HCG may be beneficial for certain individuals, including:
Men with Low Testosterone: Those experiencing symptoms such as fatigue, low libido, or reduced muscle mass and strength may benefit from TRT. Adding HCG may help support testicular function and help preserve sperm production during testosterone therapy.
Men Seeking Fertility Preservation: TRT alone may suppress spermatogenesis and reduce sperm production in some men. HCG may help maintain sperm production by stimulating the testes and supporting intratesticular testosterone levels.
Men Seeking Preservation of Testicular Function During TRT: Some men may consider combining TRT and HCG to help maintain testicular function and reduce testicular atrophy associated with suppression of the hypothalamic–pituitary–gonadal axis.
However, it is essential to consult a qualified healthcare provider to determine whether this combined therapy is appropriate for an individual’s specific health needs.
Testosterone therapy may cause acne, gynecomastia, infertility, testicular atrophy, erythrocytosis/polycythemia, and fluid retention. hCG therapy may increase estradiol levels and may contribute to gynecomastia and water retention. Injection site reactions, including pain, swelling, or irritation. It may occur with injectable therapies. TRT may suppress spermatogenesis and fertility.
Monitoring during therapy may include testosterone, estradiol, hematocrit, hemoglobin, and PSA testing. Dose adjustment and ongoing medical supervision are recommended during treatment.
United States Research on TRT with HCG is ongoing. Early studies suggest potential benefits for fertility preservation and maintenance of testicular function, but long-term safety and effectiveness have not yet been fully established.
Current clinical trials are focused on better defining how TRT with HCG should be used in men with low testosterone, including dosing and treatment protocols.
As evidence develops, TRT with HCG may become more clearly defined in clinical practice for selected patients requiring testosterone therapy with fertility considerations.
Ongoing research is also evaluating broader medical applications of HCG, including potential use in other therapeutic areas. We discuss the use of HCG in Prostate Cancer Treatment in our latest blog.
See our comprehensive range of peptides vials
(1) Madhusoodanan V, Patel P, Lima TFN, Gondokusumo J, Lo E, Thirumavalavan N, Lipshultz LI, Ramasamy R. Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL. Int Braz J Urol. 2019 Sep-Oct;45(5):1008-1012.
(2) Lee JA, Ramasamy R. Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men. Transl Androl Urol. 2018 Jul;7(Suppl 3):S348-S352.
(3) Huhtaniemi IT, Korenbrot CC, Jaffe RB. HCG binding and stimulation of testosterone biosynthesis in the human fetal testis. J Clin Endocrinol Metab. 1977 May;44(5):963-7.
Is HCG considered a peptide hormone?
HCG is considered a glycoprotein hormone made of two peptide subunits, alpha and beta. These subunits allow HCG to bind to luteinizing hormone receptors. Through this interaction, HCG stimulates testosterone production in the testes, which is why it functions similarly to luteinizing hormone in endocrine research.
Can HCG peptide cause gynecomastia?
Yes. HCG can cause gynecomastia because it may increase testosterone and estrogen levels at the same time. If estrogen rises too much compared to testosterone, breast tissue growth can occur. This side effect is more likely in sensitive individuals or with higher doses of HCG.
Does HCG peptide improve sperm count?
HCG can support sperm production by stimulating testosterone production inside the testes. Research shows some men with hormone-related infertility experience improved sperm count and motility during HCG therapy. Especially when combined with other fertility treatments like FSH. Results vary depending on the underlying cause of infertility.
Is HCG peptide effective for male infertility?
HCG may help improve male fertility by stimulating testosterone production inside the testes. This supports sperm development. Medical research shows some men with hormone-related infertility experience better sperm count and fertility outcomes during HCG therapy. Especially when it is combined with treatments such as FSH.
Does HCG peptide affect the prostate?
HCG can indirectly affect the prostate because it increases testosterone production, and testosterone influences prostate tissue activity. Research shows hormone changes from HCG therapy may slightly affect prostate-related markers like PSA. But current studies have not shown strong evidence that HCG directly causes prostate disease in healthy men.
How does HCG peptide increase estrogen levels?
HCG increases testosterone production by stimulating luteinizing hormone (LH) receptors in the testes. Some of this testosterone is then converted into estrogen through a natural process called aromatization. As testosterone levels rise during HCG therapy, estrogen levels may also increase, especially at higher doses or in sensitive individuals.
ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.
DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Direct Sarms website is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.
Save 10%
Save 10%
Can SARM AC-262 536 Treat Muscle Wasting Diseases? Muscle-wasting diseases, also called muscle atrophy disorders, cause a slow but steady loss of muscle mass. Conditions
CJC-1295 vs Ipamorelin United States: Which Peptide Supports Better Muscle Growth? CJC-1295 and Ipamorelin are two peptides often studied for their effects on muscle growth.